UNIGENE LABORATORIES INC

Profile

Company Names

UNIGENE LABORATORIES INC

Addresses

81 FULTON STREET, BOONTON, NJ 07005

Phone Numbers

973-265-1100

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$37,750,000.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2013-04-08 
$750,000.00 
$750,000.00 
$0.00 
Debt 
2
2012-09-21 
$4,000,000.00 
$7,500,000.00 
$3,500,000.00 
Debt 
1
2010-03-17 
$33,000,000.00 
$36,000,000.00 
$3,000,000.00 
Debt 
People
First Name
Middle Name
Last Name
Titles
Related Companies
J. 
THOMAS 
AUGUST 
DIRECTOR
UNIGENE LABORATORIES INC
ALLEN 
 
BLOOM 
DIRECTOR
UNIGENE LABORATORIES INC   |  REDPOINT BIO CORP   |  ADGERO BIOPHARMACEUTICALS HOLDINGS, INC.
ZVI 
 
EIREF 
DIRECTOR
PHYSICIANS FORMULA, INC.   |  PHYSICIANS FORMULA HOLDINGS, INC.   |  PHYSICIANS FORMULA DRTV, LLC   |  PHYSICIANS FORMULA COSMETICS, INC.   |  UNIGENE LABORATORIES INC
JAMES 
P. 
GILLIGAN 
EXECUTIVE OFFICER
UNIGENE LABORATORIES INC   |  HERBORIUM GROUP INC
RICHARD 
 
LEVY 
DIRECTOR
GLOBAL EMPLOYMENT HOLDINGS, INC.   |  UNIGENE LABORATORIES INC   |  VPC FUND II, L.P.   |  MONALASER, LLC   |  VPC SBIC I, LP   |  VPC SPECIALTY FINANCE FUND I, L.P.   |  VPC OFFSHORE UNLEVERAGED PRIVATE DEBT FUND, L.P.   |  VPC OFFSHORE UNLEVERAGED PRIVATE DEBT FUND FEEDER, L.P.   |  VPC SPECIALTY LENDING INVESTMENTS PLC   |  VPC INVESTOR FUND C, L.P.   |  VITALOGY OPPORTUNITY FUND LP   |  VPC INVESTOR FUND B II, LLC   |  TARSA THERAPEUTICS, INC.   |  VPC ONSHORE SPECIALTY FINANCE FUND II, L.P.   |  VPC INVESTOR FUND G-2, L.P.   |  VPC INVESTOR FUND S FEEDER, L.P.   |  VPC INVESTOR FUND M, L.P.   |  VPC INVESTOR FUND L, L.P.   |  VPC ASSET BACKED OPPORTUNISTIC CREDIT FEEDER FUND (RATED), L.P.   |  VPC ASSET BACKED OPPORTUNISTIC CREDIT FUND, L.P.   |  VPC ASSET BACKED OPPORTUNISTIC CREDIT OFFSHORE FEEDER FUND, L.P.   |  VPC ASSET BACKED OPPORTUNISTIC CREDIT FUND (LEVERED), L.P.   |  VPC SYNTHESIS, L.P.   |  VPC INVESTOR FUND P, L.P.   |  VPC OFFSHORE INVESTOR FUND P FEEDER, L.P.   |  GLIKNIK INC   |  VPC TBP SPV, LP   |  VPC ASSET BACKED OPPORTUNISTIC CREDIT FUND (LEVERED) II, L.P.   |  VPC ASSET BACKED OPPORTUNISTIC CREDIT FUND II, L.P.   |  VPC ASSET BACKED OPPORTUNISTIC CREDIT FUND II-R, L.P.
RONALD 
S. 
LEVY 
EXECUTIVE OFFICER
UNIGENE LABORATORIES INC
GREGORY 
 
MAYES 
EXECUTIVE OFFICER, DIRECTOR
UNIGENE LABORATORIES INC   |  ENGAGE THERAPEUTICS, INC.   |  ANTIOS THERAPEUTICS INC.   |  RECEPTOR HOLDINGS, INC.   |  REUNION NEUROSCIENCE MANAGEMENT, INC.   |  REUNION NEUROSCIENCE, INC.
NOZER 
M. 
MEHTA 
EXECUTIVE OFFICER
UNIGENE LABORATORIES INC
MARVIN 
 
MILLER 
DIRECTOR
UNIGENE LABORATORIES INC
BRUCE 
 
MORRA 
DIRECTOR
UNIGENE LABORATORIES INC
THERON 
 
ODLAUG 
DIRECTOR
UNIGENE LABORATORIES INC   |  ASCENDIA PHARMACEUTICALS, INC.
ASHLEIGH 
 
PALMER 
EXECUTIVE OFFICER, DIRECTOR
TARSA THERAPEUTICS, INC.   |  UNIGENE LABORATORIES INC   |  TOLERA THERAPEUTICS INC   |  THIRD POLE, INC.   |  PROVENTION BIO, INC.
THOMAS 
 
SABATINO, JR. 
DIRECTOR
UNIGENE LABORATORIES INC
PAUL 
P. 
SHIELDS 
EXECUTIVE OFFICER
UNIGENE LABORATORIES INC
PETER 
 
SLUSSER 
DIRECTOR
UNIGENE LABORATORIES INC
WILLIAM 
 
STEINHAUER 
EXECUTIVE OFFICER
UNIGENE LABORATORIES INC
ROXANNE 
 
TAVAKKOL 
EXECUTIVE OFFICER
UNIGENE LABORATORIES INC
JOEL 
 
TUNE 
DIRECTOR
UNIGENE LABORATORIES INC   |  RESQ PHARMA, INC.
JACK 
 
WYSZOMIERSKI 
DIRECTOR
UNIGENE LABORATORIES INC   |  ATHERSYS, INC / NEW
BRIAN 
 
ZIETSMAN 
EXECUTIVE OFFICER
UNIGENE LABORATORIES INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-04-22
D
Link
BIOTECHNOLOGY 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
Debt 
2013-04-08 
2012-10-09
D
Link
BIOTECHNOLOGY 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
DECLINE TO DISCLOSE 
Debt 
2012-09-21 
2010-03-29
D
Link
BIOTECHNOLOGY 
MEDICINAL CHEMICALS + BOTANICAL PRODUCTS [2833] 
$5,000,001 - $25,000,000 
Debt 
2010-03-17 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
RBC CAPITAL MARKETS CORPORATION
31194